US Edition
New drug could halt Alzheimer’s disease
- A new drug shows a better safety profile for treating Alzheimer’s disease than previous treatments.
- The drug can quickly remove plaque from the brain, outperforming lecanemab and donanemab's speed.
- Experts believe this drug could be game-changing for Alzheimer’s treatment.
- Late-Stage clinical trials for the drug are planned to begin later this year, including in the UK.
11 Articles
11 Articles
Alzheimer's breakthrough as 'game-changing' drug shown to 'suck plaque out of the brain' within weeks
A groundbreaking Alzheimer's medication has demonstrated a remarkable ability to eliminate brain plaques in fewer than 28 weeks while causing minimal adverse reactions.The experimental treatment, known as trontinemab, achieved amyloid clearance in 90 per cent of trial participants within this timeframe, according to findings unveiled at the Alzheimer's Association International Conference in Toronto.The medication's exceptional safety record and…
Alzheimer's, the Revolutionary Drug that Eliminates Markers of the Disease. "It Has No Side Effects"
A new drug called Trontinemab could revolutionize the fight against Alzheimer's disease. The first clinical results indicate that the drug is able to eliminate amyloid plaques from the brain - the main biological markers of the disease - in 90% of patients within 28 weeks, without causing significant side effects.
Trontinemab的s Phase Ib/IIa BrainshuttleTM AD study continues to show rapid and robust clearance of amyloid plaques, with 91% coming amyloid PET negative...
Coverage Details
Bias Distribution
- 57% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
